AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
RBT.PA

Robertet SA (RBT.PA) fair value

Basic Materials · Chemicals · Euronext Paris · France
€780.00+0.52%
Market cap €1.6BNext earnings 2027-04-15Updated Oct 22, 2026
Add earnings to calendarGoogle
Our verdict
Trades 22% above our fair value
Price
€780.00
Model fair valueConfidence: good
€639
Model range
€542 to €768
Fair value €639
Price €780
4 models fit Robertet SA and they partly agree: 2 of 4 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Premium(i)Bronze59
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
ACCE opinionRobertet SA (RBT.PA)
Fair value (4 models)
€639
ACCE price target
€851
Rating
Overvalued
Horizon
12 months
Fair value published on 22 Oct 2026, 13:04 CEST.
ACCE price target published on 23 Oct 2026, 01:52 CEST.
Rating published on 22 Oct 2026, 13:04 CEST.
Price used: €780 at the close on 23 Oct 2026, 17:30 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
22.1% above
-18.1% to fair value
ACCE score
47
out of 100
P/E
17.5x
forward 15.6x
1-year return
-7.4%
Dividend yield
1.56%

Robertet SA in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Robertet makes the aroma and flavour ingredients, natural extracts and fragrance compounds that go into perfumes, cosmetics, food and beverages, and it sells them to the big consumer brands on long supply contracts. The moat is in the formulation work: once a fragrance or flavour is locked into a product, customers rarely switch, and a 59.5% gross margin and 16.6% ROE say the pricing power is real. Revenue is down 0.5%, so the growth story has to come from mix, natural-ingredient demand and the next product cycle rather than volume. At 15.5x forward earnings against 17.4x trailing, the market is pricing in an earnings recovery, and with a 17.0% operating margin and a 1.6bn EUR market cap, the case rests on whether that margin holds while top-line growth turns positive again. Worth a deeper look to test that margin durability and the order book before any view on the multiple.

AI-assisted·How I use AIWritten Oct 23, 2026

Next results

Apr 15, 2027
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where RBT.PA's valuation models land
Price
€780.00
Model fair value
€639
Model range
€542 to €768
Fair value €639
Price €780
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
+0.5%
1 month
+3.3%
3 months
+1.0%
6 months
-4.1%
YTD
-11.2%
1 year
-7.4%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:52 CESTACCE price target€851first publication€776
22 Oct 2026, 13:04 CESTRatingOvervaluedfirst publication€770
22 Oct 2026, 13:04 CESTFair value€639first publication€770

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full RBT.PA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth7Value70Quality72Momentum40Total47
Valuation
Trailing P/E
17.5x
Forward P/E
15.6x
PEG
no data
P/B
2.48x
EV / Revenue
2.0x
Book value/sh
€308.44
Enterprise value
€1.6B
Profitability
ROE
16.6%
FCF yield
4.10%
ROIC
10.1%
Health and risk
Debt / equity
0.39
Dividend yield
1.56%
Beta
0.37

Price

-9.2% · 1Y

Ask anything about RBT.PA

Answered from Robertet SA fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 17% of peers
low 0.0x17.5xhigh 20.6x
ROEbetter than 67% of peers
low -11%17%high 20%
Div yieldbetter than 33% of peers
low 0.0%1.6%high 6.2%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
RBT.PA Robertet SA€780.00€63922% above17.5x16.6%7247
OLN Olin Corporation Common Stock$15.66$4465% below--10.6%2226
4061.T Denka Company Limited¥2988.50--16.0x2.6%5156
HUN Huntsman Corporation Common Stock$8.80----3.8%2241
KEMIRA.HE Kemira Oyj€15.22€1817% below15.7x9.5%5241
REX REX American Resources Corporation$39.83$2375% above10.9x19.6%7666
RDX.AX Redox LimitedA$3.50A$336% above20.6x16.6%6465

Sector report card

Where RBT.PA ranks against its sector peers on each metric.

Computing percentiles…